PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE196.45-0.95 (-0.48 %)
PREV CLOSE ( ) 197.40
OPEN PRICE ( ) 198.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8475
TODAY'S LOW / HIGH ( )194.20 198.60
52 WK LOW / HIGH ( )90 265
NSE196.55-0.65 (-0.33 %)
PREV CLOSE( ) 197.20
OPEN PRICE ( ) 197.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 196.55 (2875)
VOLUME 58939
TODAY'S LOW / HIGH( ) 194.20 198.65
52 WK LOW / HIGH ( )85.95 265
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984
Management Info
Soshil Kumar Jain - Chairman Rajesh Jain - Managing Director
Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email investorgrievances@panaceabiotec.com

Website www.panacea-biotec.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX
NEWS
03Dec Clarification
With reference to Movement in Volume, Panacea Biotec Ltd has submitted t..
05Oct Panacea Biotec gets warning letter fro
Panacea Biotec has received warning letter from US Food and Drug Adminis..
24Sep Panacea Biotec completes Phase 1/11 st
Panacea Biotec has successfully completed its Phase I/II study to evalua..
24Sep Panacea Biotec touches roof on complet
Panacea Biotec is currently trading at its upper limit of Rs. 196.80, up..
11Jun Panacea Biotec zooms on collaborating
Panacea Biotec is currently trading at Rs. 241.95, up by 39.15 points or..
Financials
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit108.1-1530.8
Gross Profit 101.3 -789.300000000001
Operating Profit 188.1-313.5
Net Sales 11821580.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 3754.85 (4.43%)
M.Cap (Rs. in Cr)9387.13
Procter&Gamble Healt (BSE)
 7178.50 (1.21%)
M.Cap (Rs. in Cr)11915.87
Jubilant LifeScience (BSE)
 927.20 (4.36%)
M.Cap (Rs. in Cr)14768.55
NGL Fine-Chem (BSE)
 1244.70 (3.17%)
M.Cap (Rs. in Cr)768.98
IOL Chem & Pharma (BSE)
 709.95 (3.55%)
M.Cap (Rs. in Cr)4167.80
Shareholding Pattern
PROMOTERS 73.59%
NON-INSTITUTION 25.02%
MUTUAL FUNDS/UTI 1.28%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
ICICI Pru Pharma He...0.87
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.